Germany Begins The Year With Two Possible Rx-To-OTC Switches
Germany Begins The Year With Two Possible Rx-To-OTC Switches
$131.00
During their bi-annual meeting, Germany’s Expert Committee for Prescription was set to discuss a move from prescription to OTC status for hydrocortisone 1% for external use, and combination ibuprofen and phenylephrine hydrochloride. Get the details of the proposal with reporting from HBW Insight.
Author: David Ridley
Publisher: HBW Insight
- Description
On January 22, 2019 the Expert Committee for Prescription of Germany was set to decide on whether or not to switch two items from prescription to over-the-counter status. Find out the details behind the proposals, which are for combination ibuprofen and phenylephrine hydrochloride, and external use hydrocortisone 1%. The move would mark the first time an ibuprofen and phenylephrine hydrochloride combination would be available in the country. HBW Insight brings you the relevant details in this informative article.
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Sign up to the